Aurobindo Pharma Share Price Jumps to Fresh 52-Week High at Rs 1,740: Here’s Why
- September 24, 2026
- Posted by: Harsh Piplani
- Category: News
Aurobindo Pharma Share Price is in focus after the stock touched a fresh 52-week high of Rs 1,739.60 and last traded at Rs 1,733.15, up 0.47% from the previous close of Rs 1,725. The move also places the company’s market capitalisation at Rs 97,641.63 crore, keeping Aurobindo Pharma Ltd. among the larger names in the Healthcare space by market value. The day’s range, from Rs 1,711.25 to Rs 1,739.60, shows that the fresh yearly high was reached during the session and the latest quote remained close to that peak.
For readers tracking Aurobindo Pharma Share Price Today, the supplied data confirms the price event but does not establish a company-specific catalyst. That makes this a data-led Aurobindo Pharma Stock News update rather than a story built around a disclosed trigger. The current price, market capitalisation, valuation ratios and sector benchmarks together provide the most useful context for Aurobindo Pharma Share Price watchers. Univest is covering the move as a fresh 52-week high event, with the next step being to read the price action alongside the company’s fundamentals, sector standing and peer comparisons.
Aurobindo Pharma Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,733.15 |
| Previous Close | Rs 1,725 |
| Today's Move | +Rs 8.15 (+0.47%) |
| Open | Rs 1,719.5 |
| High | Rs 1,739.6 |
| Low | Rs 1,711.25 |
| Turnover | Rs 0.95 crore |
| Market Capitalisation | Rs 97,641.63 crore |
Aurobindo Pharma Ltd. (AUROPHARMA) traded at Rs 1,733.15 versus the previous close of Rs 1,725, a rise of 0.47%. The stock opened at Rs 1,719.5, reached a high of Rs 1,739.6 and touched a low of Rs 1,711.25.
Aurobindo Pharma Share Price opened at Rs 1,719.50, compared with the previous close of Rs 1,725, and moved between Rs 1,711.25 and Rs 1,739.60 during the session. The current price of Rs 1,733.15 is Rs 8.15 higher than the previous close, a gain of 0.47%, while turnover stood at Rs 0.95 crore. In simple terms, the stock delivered a fresh 52-week high during the day and then stayed near that level at the latest update.
That price pattern is the core event in today’s Aurobindo Pharma Share Price Today update. The day high and 52-week high are both Rs 1,739.60, so the session printed a new yearly high at the same level. With the latest price only slightly below that peak, Aurobindo Pharma Share Price remains close to the upper end of its day’s range. The supplied data confirms the price event clearly, while not adding any company-specific explanation for why it happened. For readers following Aurobindo Pharma Stock News, the relevant question now shifts to what the financial and sector data say about the move.
Aurobindo Pharma Ltd. (AUROPHARMA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 97,641.63 crore |
| P/E Ratio | 26.73x |
| P/B Ratio | 2.55x |
| ROE | 9.93% |
| ROCE | 12.76% |
| EPS | Rs 64.52 |
| Book Value Per Share | Rs 676.49 |
| Dividend Yield | 0.23% |
Aurobindo Pharma Ltd. (AUROPHARMA) fundamental metrics show P/E 26.73x, P/B 2.55x, ROE 9.93%, ROCE 12.76%. These figures provide context only and are not a buy or sell signal.
Aurobindo Pharma Ltd. has a market capitalisation of Rs 97641.63 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 26.73x, P/B at 2.55x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 9.93% and ROCE of 12.76%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 64.52, book value per share of Rs 676.49, dividend yield of 0.23%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.33x, median ROE of 11.7%, median ROCE of 13.61%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 26.73x |
| Benchmark Median P/E | 32.33x |
| Benchmark Average P/E | 50.15x |
| Benchmark P/E Range | 3.48x to 762.66x |
| Company P/B Ratio | 2.55x |
| Benchmark Median P/B | 3.04x |
| Company ROE | 9.93% |
| Benchmark Median ROE | 11.7% |
| Company ROCE | 12.76% |
| Benchmark Median ROCE | 13.61% |
| Company Market Capitalisation | Rs 97,641.63 crore |
| Benchmark Median Market Cap | Rs 745.38 crore |
Aurobindo Pharma Ltd. (AUROPHARMA) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Aurobindo Pharma Ltd. (AUROPHARMA) has a P/E ratio of 26.73x, which is below the benchmark median of 32.33x, a difference of -17.32%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Aurobindo Pharma Ltd. (AUROPHARMA) has a ROE of 9.93%, which is below the benchmark median of 11.7%, a difference of -15.13%. Aurobindo Pharma Ltd. (AUROPHARMA) has a ROCE of 12.76%, which is below the benchmark median of 13.61%, a difference of -6.25%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Lupin Ltd. | LUPIN | 96,950.05 | 17.37 | 4.03 | 27.11 | 28.86 |
| Dr. Reddy's Laboratories Ltd. | DRREDDY | 1,01,163.25 | 31.35 | 2.65 | 11.69 | 13.75 |
| Mankind Pharma Ltd. | MANKIND | 1,02,410.4 | 49.79 | 6.04 | 12.69 | 13.24 |
| Laurus Labs Ltd. | LAURUSLABS | 1,08,338 | 100.55 | 19.5 | 18.31 | 18.2 |
| Cipla Ltd. | CIPLA | 1,11,565.25 | 33.08 | 3.17 | 11.83 | 16 |
Aurobindo Pharma Ltd. (AUROPHARMA) has a P/E ratio of 26.73x compared with the displayed peer median of 33.08x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 9.93% compares with a peer median of 12.69% across the companies shown in the table. ROCE stood at 12.76% versus the displayed peer median of 16%, providing a capital-efficiency comparison. Aurobindo Pharma Ltd. (AUROPHARMA) has a market capitalisation of Rs 97,641.63 crore. Among the 5 peers shown, 4 have a larger market capitalisation.
Why Investors Are Watching Aurobindo Pharma
- Aurobindo Pharma Share Price touched a fresh 52-week high of Rs 1,739.60.
- The latest price was Rs 1,733.15, up 0.47% from the previous close of Rs 1,725.
- Market capitalisation stood at Rs 97,641.63 crore in the supplied record.
- P/E of 26.73 and P/B of 2.55 sit below the same-industry medians of 32.33 and 3.04.
- Revenue and net profit both rose between Jun 2025 and Jun 2026 in the supplied financials.
About Aurobindo Pharma
Aurobindo Pharma Ltd. operates in the Pharmaceuticals & Drugs industry within the Healthcare sector. The supplied data focuses on company-level market cap, valuation ratios, profitability measures and recent financial performance, which are the main points relevant to this Aurobindo Pharma Share Price update. In the present dataset, the business description is intentionally limited to sector and industry classification, so the article stays close to verified facts. That also keeps the Aurobindo Pharma Company News coverage grounded in what is explicitly available for readers of Aurobindo Pharma Share Price Today and related stock updates on Univest.
Track Aurobindo Pharma Share Price on Univest
Use Aurobindo Pharma Ltd. (AUROPHARMA) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Readers can track Aurobindo Pharma Share Price on Univest for live price updates, share price news, market cap, shareholding pattern, 52-week levels, valuation ratios and company fundamentals. Univest also presents company-specific stock analysis, sector context and peer comparisons in one place for easy monitoring.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Aurobindo Pharma Share Price hit a fresh 52-week high?
Ans. The supplied data confirms that Aurobindo Pharma Share Price touched Rs 1,739.60, a fresh 52-week high, but it does not establish a company-specific catalyst. The record is best read as a verified price event.
What is Aurobindo Pharma Share Price today?
Ans. Aurobindo Pharma Share Price was Rs 1,733.15, up 0.47% from the previous close of Rs 1,725. The stock also traded between Rs 1,711.25 and Rs 1,739.60 during the session. The stock moved 0.47% during the session.
What is the 52-week high for Aurobindo Pharma Share Price?
Ans. The fresh 52-week high for Aurobindo Pharma Share Price is Rs 1,739.60. The latest quoted price remained close to that level, which is why the stock is in focus in today’s market update.
How is Aurobindo Pharma valued against its industry?
Ans. Aurobindo Pharma trades at a P/E of 26.73 and P/B of 2.55. Both are below the same-industry medians of 32.33 and 3.04, based on the supplied healthcare benchmark. The stock belongs to the Healthcare sector.
What do Aurobindo Pharma profitability ratios show?
Ans. Aurobindo Pharma reports ROE of 9.93% and ROCE of 12.76%. Those figures are below the benchmark medians of 11.7% and 13.61%, which provides useful context for the share price move.
How does Aurobindo Pharma compare with peers?
Ans. Aurobindo Pharma’s market cap of Rs 97,641.63 crore is broadly similar to Lupin’s Rs 96,950.05 crore and below several other peers. Its valuation sits between lower and higher peer multiples in the supplied set.
What are the key financial figures for Aurobindo Pharma?
Ans. The supplied figures include market cap of Rs 97,641.63 crore, EPS of Rs 64.52, book value of Rs 676.49 and dividend yield of 0.23%. Revenue and net profit also rose year on year in the latest quarterly data.
What sector does Aurobindo Pharma belong to?
Ans. Aurobindo Pharma belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. That sector placement helps frame the company’s valuation, profitability and peer comparison in today’s Aurobindo Pharma Stock News.
